Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (NYSE: NVO)

 
NVO Technical Analysis
5
As on 23rd Feb 2026 NVO STOCK Price closed @ 39.63 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 70.94 & Strong Sell for SHORT-TERM with Stoploss of 90.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NVOSTOCK Price

Open 40.19 Change Price %
High 41.09 1 Day -7.79 -16.43
Low 39.34 1 Week -9.11 -18.69
Close 39.63 1 Month -17.71 -30.89
Volume 94880902 1 Year -67.17 -62.89
52 Week High 111.69 | 52 Week Low 39.63
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
SWN 7.11 -0.56%
HBI 6.47 0.00%
BACA-U 302.00 0.67%
NVO 39.63 -16.43%
ENLC 14.12 -0.21%
IPG 24.57 -1.96%
CADE 42.11 -1.66%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
WE 0.50 42.86%
WE 0.50 42.86%
KUKE 1.39 39.00%
DMS 0.45 36.36%
BFLY-WS 0.04 33.33%
 
NYSE USA Top Losers Stocks
NUVB-WS 0.00 -100.00%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
 
 
NVO
Daily Charts		 NVO
Intraday Charts		 Whats New @
Bazaartrend		 NVO
Free Analysis
 
NVO Important Levels Intraday
RESISTANCE43.00
RESISTANCE41.92
RESISTANCE41.25
RESISTANCE40.58
SUPPORT38.68
SUPPORT38.01
SUPPORT37.34
SUPPORT36.26
 
NVO Forecast February 2026
Share
4th UP Forecast63.04
3rd UP Forecast55.53
2nd UP Forecast50.89
1st UP Forecast46.25
1st DOWN Forecast33.01
2nd DOWN Forecast28.37
3rd DOWN Forecast23.73
4th DOWN Forecast16.22
 
NVO Weekly Forecast
4th UP Forecast47.86
3rd UP Forecast45.22
2nd UP Forecast43.59
1st UP Forecast41.96
1st DOWN Forecast37.30
2nd DOWN Forecast35.67
3rd DOWN Forecast34.04
4th DOWN Forecast31.40
 
NVO Forecast2026
4th UP Forecast180.61
3rd UP Forecast135.4
2nd UP Forecast107.45
1st UP Forecast79.5
1st DOWN Forecast-0.24
2nd DOWN Forecast-28.19
3rd DOWN Forecast-56.14
4th DOWN Forecast-101.35
 
 
NVO Other Details
Segment EQ
Market Capital 247091216384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NVO Address
NVO
 
NVO Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NVO Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service